DaCapo Brainscience
Warren Hirst is currently serving as the Senior Vice President Research at DaCapo Brainscience, a seed-stage company focused on neurodegenerative disease progression. Prior to this role, Warren held various positions at Biogen, Pfizer, and GlaxoSmithKline, accumulating valuable experience in the field. Warren's educational background includes studies at Imperial College London from 1989 to 1998.
This person is not in any teams
DaCapo Brainscience
DaCapo's mission is to develop the first disease-modifying therapies for neurodegenerative diseases.